December 16, 2024
Treace Announces First Surgical Cases Utilizing the SpeedPlate™ MicroQuad™ Implant
December 4, 2024
Treace Announces First Cases Utilizing RedPoint™ Intelliguide™ Patient Specific Instrumentation with the Adductoplasty® System for Correction of Midfoot Deformities
December 2, 2024
Treace Appoints Guy Guglielmino as Chief Commercial Officer
November 18, 2024
Treace Announces Participation at Stifel 2024 Healthcare Conference
November 5, 2024
Treace Medical Concepts Reports Third Quarter 2024 Financial Results
November 4, 2024
Treace Announces Participation in the UBS Global Healthcare Conference
November 4, 2024
Treace Comments on CMS’ 2025 Final Rule for Hospital Outpatient and ASC Settings
November 4, 2024
Treace Enters High Volume Osteotomy Market with Nanoplasty™ 3D Minimally Invasive Bunion Correction™ Procedure
October 22, 2024
Treace to Report Third Quarter 2024 Financial Results on November 5, 2024
October 14, 2024